Analysts See $0.28 EPS for Safety, Income & Growth Inc. (SAFE); Last Week Abbott Laboratories (ABT) Coverage

April 19, 2018 - By Peter Erickson

Abbott Laboratories (NYSE:ABT) Logo

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Friday, September 22 by Stifel Nicolaus. The stock has “Equal-Weight” rating by Morgan Stanley on Tuesday, July 11. The company was reinitiated on Wednesday, June 21 by BTIG Research. As per Tuesday, September 13, the company rating was maintained by Jefferies. The stock has “Buy” rating by Jefferies on Wednesday, January 24. On Wednesday, January 24 the stock rating was maintained by BMO Capital Markets with “Buy”. The firm earned “Buy” rating on Monday, June 26 by RBC Capital Markets. The rating was upgraded by Morgan Stanley to “Overweight” on Tuesday, January 2. The rating was downgraded by Piper Jaffray on Thursday, April 28 to “Neutral”. On Monday, August 10 the stock rating was reinitiated by Credit Suisse with “Outperform”. See Abbott Laboratories (NYSE:ABT) latest ratings:

30/01/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $59 New Target: $64 Maintain
30/01/2018 Broker: Argus Research Rating: Buy New Target: $80.0
25/01/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $66 New Target: $70 Maintain
25/01/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $65 New Target: $69 Maintain
25/01/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $67 New Target: $70 Maintain
24/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $67.0 Maintain
25/01/2018 Broker: Wells Fargo Rating: Outperform Old Target: $66 New Target: $70 Maintain
25/01/2018 Broker: William Blair Rating: Buy Upgrade
25/01/2018 Broker: Guggenheim Rating: Buy New Target: $72.0 Maintain
24/01/2018 Broker: BMO Capital Markets Rating: Buy New Target: $70.0 Maintain

Analysts expect Safety, Income & Growth Inc. (NYSE:SAFE) to report $0.28 EPS on May, 17.SAFE’s profit would be $5.09 million giving it 15.71 P/E if the $0.28 EPS is correct. After having $-0.07 EPS previously, Safety, Income & Growth Inc.’s analysts see -500.00% EPS growth. The stock decreased 0.28% or $0.05 during the last trading session, reaching $17.6. About 22,457 shares traded. Safety, Income & Growth Inc. (NYSE:SAFE) has 0.00% since April 19, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock increased 0.60% or $0.36 during the last trading session, reaching $59.88. About 6.55 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 19, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Abbott Laboratories manufactures and sells health care products worldwide. The company has market cap of $104.57 billion. The companyÂ’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. It has a 222.6 P/E ratio. The Company’s Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic tests; informatics and automation solutions; and a suite of informatics tools and professional services.

Since October 23, 2017, it had 1 buy, and 19 selling transactions for $28.95 million activity. Another trade for 3,000 shares valued at $183,579 was sold by Watkin Jared. The insider Funck Robert E sold 1,220 shares worth $71,970. 6,284 Abbott Laboratories (NYSE:ABT) shares with value of $375,381 were sold by Contreras Jaime. BIRD ROGER had sold 8,262 shares worth $518,450. Blaser Brian J sold $1.73M worth of stock or 27,733 shares. Bracken Sharon J sold $62,056 worth of stock. Shares for $3.36M were sold by Fussell Stephen R on Friday, February 16.

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold Abbott Laboratories shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Mcdaniel Terry Co reported 0.14% in Abbott Laboratories (NYSE:ABT). Cubist Systematic Strategies Ltd Llc holds 0.16% in Abbott Laboratories (NYSE:ABT) or 51,579 shares. Buffington Mohr Mcneal, Idaho-based fund reported 72,465 shares. Illinois-based Front Barnett Assoc Ltd Liability Com has invested 0.16% in Abbott Laboratories (NYSE:ABT). Ramsay Stattman Vela & Price Incorporated, a Colorado-based fund reported 136,569 shares. Comerica Securities Inc reported 66,615 shares stake. Albion Gru Ut reported 4,335 shares. Edmp invested in 0.91% or 18,217 shares. Parsons Capital Ri reported 114,511 shares. Churchill Management stated it has 32,887 shares. Alphaone Invest Services Limited Com owns 1,315 shares for 0.02% of their portfolio. Altavista Wealth holds 0.15% in Abbott Laboratories (NYSE:ABT) or 6,137 shares. Appleton Prns Ma reported 0.18% in Abbott Laboratories (NYSE:ABT). Kazazian Asset Mngmt Lc holds 0.62% or 10,688 shares. 567,816 are held by Capital Fund Mgmt Sa.

Among 4 analysts covering Safety Income & Growth Inc (NYSE:SAFE), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Safety Income & Growth Inc had 7 analyst reports since July 14, 2017 according to SRatingsIntel. The company was maintained on Friday, July 14 by Ladenburg. The stock of Safety, Income & Growth Inc. (NYSE:SAFE) has “Hold” rating given on Monday, July 17 by Barclays Capital. The firm has “Hold” rating by J.P. Morgan given on Monday, July 17. As per Monday, July 31, the company rating was maintained by Ladenburg. The stock has “Hold” rating by Mizuho on Thursday, October 26. The company was maintained on Tuesday, October 31 by Ladenburg. Mizuho initiated the stock with “Hold” rating in Thursday, August 31 report.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.